Behavior Modification Wristwatch
A wristwatch including a watch band and a watch body having an octagon shaped perimeter and being red in color and having the word STOP thereon to resemble a stop sign.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120107829 | STABILIZING COMPOSITIONS FOR IMMOBILIZED BIOMOLECULES The present invention relates to the use of a composition comprising (a) at least three different amino acids, (b) at least two different amino acids and a saponin or (c) at least one dipeptide or tripeptide for stabilizing biomolecules immobilized on a solid carrier. T... | 05/03/2012 |
| 20120108526 | ANTI-MICROBIAL COMPOSITIONS Antimicrobial compounds from Epicoccum purpurascens (syn. E. negrum) for use against plant and fungi pathogens. An orange yellow metabolite was isolated, the structure elucidated as a small group of compounds Epipyrone A-C and fungicidal activity demonstra... | 05/03/2012 |
| 20120070511 | MITOCHONDRIAL INHIBITORS AND USES THEREOF Compositions which modulate mitochondrial functions treat diseases associated with cells that are hyperactively using their endoplasmic reticulum. Screening assays identify agents which modulate mitochondrial functions.... | 03/22/2012 |
| 20120045429 | Methods and Agent for Modulating the RNA Polymerase II-Histone Surface The present invention relates to the identification of an intranucleosomal DNA loop formed during transcription through a nucleosome and use of the same to identify an agent that modulates the RNA Polymerase II-histone surface.... | 02/23/2012 |
| 20120046223 | EXOGENOUSLY TRIGGERED CONTROLLED RELEASE MATERIALS AND USES THEREOF The disclosure provides cross-linked materials that include multivalent cross-linking agents that bind an exogenous target molecule; and conjugates that include two or more separate affinity ligands bound to a conjugate framework, where in the two or more affinity ligan... | 02/23/2012 |
| 20120028267 | METHOD FOR INCREASING SENSITIVITY USING LINKER AND SPACER IN CARBON NANOTUBE-BASED BIOSENSOR Disclosed is a method of detecting even a very small amount of a target substance by mixing a linker and a spacer at a suitable ratio and immobilizing the mixture on the surface of carbon nanotubes in a carbon nanotube-based biosensor. This method detects a specific sub... | 02/02/2012 |
| 20120015841 | NOVEL CELL LINES AND METHODS The invention relates to novel cells and cell lines, and methods for making and using them.... | 01/19/2012 |
| 20120015397 | Periodontal Disease Marker (as amended herewith) A marker for determining the onset of periodontal disease and a marker for determining the progression stage of periodontal disease, each containing autoinducer-2.... | 01/19/2012 |
| 20110319348 | BRASSINOSTEROIDS IN TREATING PROSTATIC HYPERPLASIA AND ANDROGENIC ALOPECIA Provided are formulations containing brassinosteroids or their derivatives for treating androgen-associated conditions, such as prostate problems. Particularly formulations comprising at least one brassinosteroid or a derivative thereof are provided for treating benign ... | 12/29/2011 |
| 20110301083 | CONJUGATE BASED SYSTEMS FOR CONTROLLED DRUG DELIVERY Conjugates which comprise a drug and a ligand which includes a first saccharide; wherein the conjugate is characterized in that, when the conjugate is administered to a mammal, at least one pharmacokinetic or pharmacodynamic property of the conjugate is sensitive to ser... | 12/08/2011 |
| 20110302669 | MAIZE VARIETY AND METHOD OF PRODUCTION The disclosure relates to a maize plant, seed, variety, and hybrid. More specifically, the disclosure relates to a maize plant containing a Cal-1 allele, whose expression results in increased cell wall-derived glucan content in the maize plant. The disclosure also relat... | 12/08/2011 |
| 20110281807 | PLANT DISEASE CONTROL AGENT COMPRISING D-TAGATOSE AS ACTIVE INGREDIENT, AND PLANT DISEASE CONTROL METHOD A plant disease control agent comprising D-tagatose as an active ingredient; and a plant disease control agent comprising at least one member selected from the group consisting of saccharides and substances each having a bactericidal and/or fungicidal activity. The plan... | 11/17/2011 |
| 20110275579 | ANTI-DIABETIC EXTRACT OF ROOIBOS Novel and useful compositions derived from rooibos for treating diabetes are provided. The present invention is particularly concerned with the treatment of Type 2 diabetes. The invention provides a new use for aspalathin and rutin and compositions containing them for u... | 11/10/2011 |
| 20110271371 | PLANTS AND SEEDS OF CORN VARIETY CV970480 According to the invention, there is provided seed and plants of the corn variety designated CV970480. The invention thus relates to the plants, seeds and tissue cultures of the variety CV970480, and to methods for producing a corn plant produced by crossing a corn plan... | 11/03/2011 |
| 20110262988 | METHODS AND COMPOSITIONS FOR ENHANCED BACTERIAL HYDROLYSIS OF CELLULOSIC FEEDSTOCKS The present invention provides compositions comprising a cellulolytic bacterium and an isolated BETA-glucosidase enzyme or comprising cellulolytic bacterium that expresses a secreted recombinant BETA-glucosidase enzyme, and methods of using same for hydrolysis of cellul... | 10/27/2011 |
| 20110258742 | Stress Tolerant Transgenic Crop Plants Disclosed herein are novel variant bacterial cold shock proteins and recombinant DNA for expressing such proteins to produce transgenic plants with enhanced stress tolerance and/or enhanced yield.... | 10/20/2011 |
| 20110251383 | Process For Making Polyol Esters With Improved Colour And Odour Quality Suggested is an improved process for making polyol esters with improved colour quality by transesterification of polyols or their alkoxylation products with fatty acid alkyl esters, which is characterised in that the reaction is carried out in the presence of a reducing... | 10/13/2011 |
| 20110250534 | SOLUBILIZER FOR METAL IONS The invention relates to solubilizers for metal ions and poorly soluble metal compounds, containing an oxidation product of starch hydrolysate as a solubilizing agent, to a method for solubilizing metal ions and to the use of said solubilizer.... | 10/13/2011 |
| 20110245490 | C-GLYCOSIDE COMPOUNDS, AND METHOD FOR PREPARING C-GLYCOSIDE COMPOUNDS The invention relates to C-glycose compounds of formula (I) where: S′ is a monosaccharide radical or a polysaccharide radical derived from a monosaccharide or polysaccharide S; R is a linear or branched alkyl radical; and Z is an ethylenyl CH═CR1(R2) or an acetyleny... | 10/06/2011 |
| 20110237657 | Transport-Mediating Colloidal Pharmaceutical Compounds The invention relates to transport mediator-bonded colloids comprising pharmaceutical substances or fluorescence markers, to a method for the production thereof, and to a pharmaceutical preparation comprising said compounds.... | 09/29/2011 |
| 20110231946 | ENGINEERING OF BOLTING RESISTANCE IN SUGAR BEET BY MEANS OF THE TRANSGENIC EXPRESSION OF THE BEET HOMOLOGUE OF FLOWERING TIME CONTROL GENE FT This invention relates to the field of bolting and flowering time control in sugar beet, specifically to methods as well as nucleic acid molecules, chimeric constructs, and vectors for engineering bolting resistance in sugar beet by means of altering the expression of t... | 09/22/2011 |
| 20110220358 | ASSEMBLIES FOR THE PURIFICATION OF A RESERVOIR OR PROCESS FLUID A sugar-based assembly is provided for the removal of a component from a reservoir or process fluid. The sugar-based assembly comprises a sugar optionally bound to a support, and where the support is present, the sugar is bound directly to the support or via a linker gr... | 09/15/2011 |
| 20110212906 | C-LINKED GLUCURONIDE OF N-(4-HYDROXYBENZYL) RETINONE, ANALOGS THEREOF, AND METHODS OF USING THE SAME TO INHIBIT NEOPLASTIC CELL GROWTH Compounds of the formula: are described, along with pharmaceutical compositions containing these compounds, and methods of using the compounds to prevent and to treat cancer in mammals, including humans.... | 09/01/2011 |
| 20110212888 | Diet and methods for improving learning capacity, mood and behavior in mammals This invention provides a method of improving mood and learning capacity in a mammal by giving the mammal a meal of low protein food, followed by a second meal of high glycemic index carbohydrate. A composition to be given to a mammal to improve mood and learning capaci... | 09/01/2011 |
| 20110201801 | SACCHARIDE STRUCTURES AND METHODS OF MAKING AND USING SUCH STRUCTURES Described are oligosaccharides having a protecting group at two, a plurality, a majority of, or each position in the oligosaccharide which is amenable to derivatization. Collections, libraries and methods of making and using such oligosaccharides are also described.... | 08/18/2011 |
| 20110177154 | Tubular nanostructure targeted to cell membrane Devices, compositions, and methods are described which provide a tubular nanostructure or a composite tubular nanostructure targeted to a lipid bilayer membrane. The tubular nanostructure includes a hydrophobic surface region flanked by two hydrophilic surface regions. ... | 07/21/2011 |
| 20110144281 | AMPHIPHILIC POLYMERS HAVING A CHOLANE CORE The present invention relates to a polymer comprising a cholane core having at least one derivatizable group covalently bonded thereto and a hydrophilic polymer chain covalently bonded to derivatizable group(s) and a process for producing it The present invention also r... | 06/16/2011 |
| 20110129500 | LAWSONIA INTRACELLULARIS BACTERIUM OF A NOVEL SEROTYPE, VACCINE BASED ON THAT BACTERIUM, ANTIBODIES SUITABLE FOR DIAGNOSING THE NOVEL LAWSONIA INTRACELLULARIS SEROTYPE AND HYBRIDOMAS FOR PRODUCING THE SAID ANTIBODIES This invention pertains to Lawsonia intracellularis bacterium of a serotype which is reactive with monoclonal antibody INT-LIC-02-02 as produced by hybridoma INT-LIC-02-02 deposited with the Collection Nationale de Cultures de Micro-organismes of the Institut Pas... | 06/02/2011 |
| 20110123976 | Biomarkers and identification methods for the early detection and recurrence prediction of breast cancer using NMR A method is provided for the parallel identification of one or more metabolite species within a biological sample. The method comprises analyzing the sample to produce a spectrum containing individual spectral peaks representative of the one or more metabolite species c... | 05/26/2011 |
| 20110112042 | NOVEL FLAVONOL COMPOUNDS, A BIOACTIVE EXTRACT/FRACTION FROM ULMUS WALLICHIANA AND ITS COMPOUNDS FOR PREVENTION FOR TREATMENT OF OSTEO-HEALTH RELATED DISORDERS The present invention provides a flavonol compound and a bioactive extract/fraction from Ulmus wallichiana useful for the management or prevention or treatment of bone disorders. Said extract/fraction comprising marker compounds of general formula 2, K058: R... | 05/12/2011 |
| 20110110893 | THERAPEUTIC AGENT FOR ANAEROBIC DISEASES The present invention provides a therapeutic agent for anaerobic diseases such as solid tumor, comprising in combination a pharmaceutical composition for the treatment of an anaerobic disease containing the transformed anaerobic microorganism as an active component and ... | 05/12/2011 |
| 20110104072 | TREATING WATER INSOLUBLE NANOPARTICLES WITH HYDROPHILIC ALPHA-HYDROXYPHOSPHONIC ACID CONJUGATES, THE SO MODIFIED NANOPARTICLES AND THEIR USE AS CONTRAST AGENTS The present application discloses treating water insoluble nanoparticles, particularly nanoparticles of metals and metal compounds which find utility in diagnostic imaging such as MR and X-ray imaging, with an alpha-hydroxyphosphonic acid conjugate with a hydrophilic mo... | 05/05/2011 |
| 20110098365 | SALT PRODUCT A method of preparing a salt product comprises the steps of: (i) providing a mixture which comprises salt dissolved in a solvent, said mixture further containing an organic material that is solid under ambient temperature conditions; and (ii) atomising said mixture and ... | 04/28/2011 |
| 20110097765 | ENHANCED FERMENTATION PROCESS USING MOLASSES Described herein are compositions and methods for enhanced fermentation of molasses using transglucosidase.... | 04/28/2011 |
| 20110070620 | SUBSTRATES COMPRISING SWITCHABLE FERROMAGNETIC NANOPARTICLES In a process for producing organic substrate particles bonded to switchable ferromagnetic nanoparticles with a mean particle diameter in the range from 10 to 1000 nm, the ferromagnetic nanoparticles used are those nanoparticles which are nonferromagnetic at first, but b... | 03/24/2011 |
| 20110071094 | (D)-ALLOSE INDUCING PROGRAMMED CELL DEATH IN HORMONE REFRACTORY PROSTATE CANCER LINES The present disclosure relates allose inducing programmed cell death in hormone refractory prostate cancer cell lines. More particularly, the present disclosure relates to a D-allose inducing programmed cell death in hormone refractory prostate cancer cell line of DU145... | 03/24/2011 |
| 20110059907 | Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care This invention relates to certain complexes of ascorbic acid and its derivatives with certain natural antioxidant and anti-inflammatory ketones for topical or oral application; said complexes having general chemical formula (I), its isomers, and salts thereof, including... | 03/10/2011 |
| 20110053868 | L-SUGAR COLON CLEANSING AGENT AND USES THEREOF Disclosed is L-glucose monohydrate and compositions thereof. Also disclosed are methods for making L-glucose monohydrate and compositions thereof. Further disclosed are methods for colonic cleansing using L-sugars, such as L-glucose monohydrate, and compositions and kit... | 03/03/2011 |
| 20110045021 | SUGAR IMMUNOGENS Disclosed are compositions and methods useful for inducing an immunogenic response in a subject or host. In particular, the compositions and methods may be directed to carbohydrate HIV vaccines and to methods of producing a carbohydrate HIV vaccine by introducing antige... | 02/24/2011 |
| 20110046346 | BIOMATERIAL WITH FUNCTIONALISED SURFACES There is provided a biomaterial having a functionalised surface which comprises bi-functional semi-dendrimers. The biomaterial may be ceramic, metallic and/or polymeric. It will usually be in the form of a solid, but could be a semi-solid or hydrogel. There is also prov... | 02/24/2011 |